Neuro-oncology: WTD

What's the data?

Veröffentlicht von: Limbix

Beschreibung

Neuro-oncology: What's the data?, 3rd edition
This is the app that puts the power of knowledge in the palm of your hand! Essential literature, including a voluminous body of randomized, controlled trials, is reviewed and presented in an easy-to-read format. The user can review seminal studies on a topic in seconds.
Staff surgeons, review and update your knowledge quickly, between clinic patients, if necessary!
Residents and medical students, get bulletproof protection from unpleasant pimp sessions!
PAs and NPs, get the information you need, fast!
Over two hundred references are included, covering topics in the major areas of surgical and medical management of tumors of the central nervous system. Citation information is included, permitting the user to pursue additional, in-depth study.
No matter what your level of training or expertise, this app can make you better! 
Users should be aware that the content of this app overlaps with that of another app, entitled "Neurosurgery: What’s the data?", which covers the breadth of neurosurgery.
------------------------------------------------------------------------------------------
The annual subscription fee is $1.99.
This is an auto-renewing subscription app - content is updated every 1-3 months
Payment information will be verified at time of purchase; if subscription is not cancelled before the end of the 3-day free trial, your credit card will be charged.
Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period.
Account will be charged for renewal within 24-hours prior to the end of the current period, and identify the cost of the renewal.
Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase.
Terms of Use:
https://whatsthedata.com/terms-of-use
Privacy policy: 
https://whatsthedata.com/privacy-policy
Ausblenden Mehr anzeigen...

In-App-Käufe

Annual Subscription
$3.49

Screenshots

Neuro Häufige Fragen

  • Ist Neuro kostenlos?

    Ja, Neuro ist kostenlos herunterzuladen, enthält jedoch In-App-Käufe oder Abonnements.

  • Ist Neuro seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Neuro?

    Neuro bietet mehrere In-App-Käufe/Abonnements, der durchschnittliche In-App-Preis beträgt 3.49 $.

  • Wie hoch ist der Umsatz von Neuro?

    Um geschätzte Einnahmen der Neuro-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Neuseeland noch nicht bewertet.
Bewertungsverlauf

Neuro Bewertungen

I love this app

NHNeurosurgeon on

Vereinigte Staaten

Concise, evidence-based summaries, very useful in day to day practice.

Super!

WSL2005 on

Vereinigte Staaten

Must-have for anyone treating patients with brain tumors

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Neuro Konkurrenten

Name
Manual of Clinical Oncology
with Expert Recommentations
Neuro-Oncology Trials App
Immuno-Oncology
from @ Point of Care™
Metastatic Spine
Spinal Oncology Care
Neurosurgery Operative Notes
Templates and Custom Notes
RO Toolbox
Endovascular Neurosurgery
Custom Surgical Notifications
BarrowNeuro TV
Minding What Matters Most
Nakhla Neurosurgery
Custom Surgical Notifications
UCLA Neurosurgery

Neuro Installationen

Letzte 30 Tage

Neuro Umsatz

Letzte 30 Tage

Neuro Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Neuro mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.